Concepedia

Tolerability and Dose Proportional Pharmacokinetics of Pasireotide Administered as a Single Dose or Two Divided Doses in Healthy Male Volunteers: A Single-Center, Open-Label, Ascending-Dose Study

Stephan Petersenn, Ke Hu, Mario Maldonado, Yilong Zhang, Janet Lasher, Emmanuel Bouillaud, Yanfeng Wang, Klaus Mann, Nicole Unger

Clinical Therapeutics · 2012 · 17 citations · 9 references

DOI

Concepts

References

9

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects

Journal of obstetrics and gynaecology research · 2001 · 3.5K citations · Full text

, , +13

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

Christian Bruns, Ian Lewis, U. Briner et al. · European Journal of Endocrinology · 2002 · 687 citations

, , +16

Confidence Interval Criteria for Assessment of Dose Proportionality

Brian P. Smith · Pharmaceutical Research · 2000 · 352 citations

, , +13

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

Marco Boscaro, W.H. Ludlam, Brew Atkinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 279 citations · Full text

, , +15

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Joost van der Hoek, Wouter W. de Herder, Richard A. Feelders et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 142 citations · Full text

, , +17